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ABSTRACT
Introduction: Malaria is still a major cause of severe illness which is responsible for millions of deaths, mostly in children under 5 years old. A major 
problem to malaria vaccine production is the identification of protective epitopes and respective protective antibody.
Objective: A cross-sectional study was carried out in a representative cohort of children in Minna aged 6 months–17 years to determine the correlation 
between immunoglobulin G (IgG) antibody responses to Plasmodium falciparum merozoite antigens.
Methods: Plasma samples from 93 children were exposed to Enzyme-Linked Immunosorbent Assay for the measurement of IgG antibody production 
against P. falciparum.
Results: There was a high seroprevalence of IgG antibody against P. falciparum antigens tested with 74.20%. The seroprevalence for the male 
category was quite higher as compared with that of the female category, though, analysis using Mann–Whitney U-test revealed IgG antibody response 
to P. falciparum infection in the male was significantly different as compared to the female category (p<0.05). Furthermore, the prevalence of IgG 
antibody against P. falciparum antigen increased with age, with the lowest observed in 6 months–5 years 66.66%. Kruskal–Wallis H test showed 
a non-significant difference in the production of IgG antibody against P. falciparum antigen between different cohorts, and no correlation exists 
between them (p>0.05). An evidence of more than 50% was found for the production of IgG antibody by sub-microscopic parasite. On the other hand, 
microscopically positive P. falciparum samples recorded more seroprevalence of 68.81% as against negative samples, though significant difference 
between the negative and positive P. falciparum infected samples and the production of IgG antibody was not observed (p>0.05).
Conclusion: This study has demonstrated a boosting immune responses by sub-microscopic parasite and also suggests a strong relationship between 
production of IgG antibody and malaria transmission, rather than protective immunity.
Keywords: Antibody, Antigen, Enzyme-linked immunosorbent assay, Immunoglobulin, Malaria, Plasmodium falciparum.
INTRODUCTION
Plasmodium falciparum remains a major cause of malaria which is 
responsible for millions of deaths worldwide with mostly children 
being affected. Malaria accounts for about 69% deaths worldwide 
among these children [1] and a total of 191 million cases and over 390 
thousand deaths reported in 2016. In Nigeria, there were an estimated 
33,000 malaria cases per 100,000 people, with 110,000 of these cases 
resulting in deaths [2]. Although, there has been a gradual decline in 
the prevalence of malaria among Nigerian children over the years (from 
42% in 2010 to 27% in 2015), malaria remains a leading cause of death 
among them [2]. 
Due to the endemic nature of malaria in Nigeria, partial immunity to 
malaria is acquired. Hence, individuals living in malaria endemic areas 
develop naturally acquired immunity to Plasmodium spp. infections as 
they age, but this occurs slowly and after repeated exposure [3,4], then 
capability of controlling parasitemia in the blood is then developed at a 
later stage. Studies have shown that antibodies contribute to protection 
against clinical malaria due to P. falciparum. Antibodies directed against 
cell surface proteins of either the merozoite form of the parasite or of 
infected red blood cells have been shown to be important components 
of acquired protective immunity against malaria [5].
Meanwhile, the development of partial immunity to clinical malaria 
is antigen-specific, mediated by exposure to various genetically 
distinct parasite subpopulations, which are referred to as clones. 
There is usually a cross-protection conferred by antigenically similar 
clones [6]. In areas of high malaria transmission, residents are often 
exposed to a diversity of clones, which results in a rapid development 
of anti-malaria immunity and asymptomatic infections [7]. In areas 
of low transmission; however, there is a lower rate of multiclonal 
infections and anti-disease immunity develops more slowly [8]. This 
study focuses at determining the seroprevalence of immunoglobulin 
(IgG) antibody responses against P. falciparum merozoite antigens. 
At any rate, malaria elimination and control is important, and control 
measures require, in part, adequate understanding of acquired 
immunity and how it relates to parasite burden in the host. This study 
seeks to obtain information and provide baseline data on acquired 
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Government, respectively. Furthermore, informed consent was obtained 
from the parents or guardians of children captured in this study.
Sample collection
The study was conducted in Minna, the capital city of Niger state in 
North Central Nigeria located at 9.62 latitude and 6.55 longitude and 
situated at elevation 243 m above sea level, covering a land area of 
88 km2. It has an estimated population of 1.2 million. In this area, no 
fewer than 19,000 children below 5 years old, die of malaria annually, 
making it the region with the highest number of child deaths from 
malaria in the north central zone of the country [9]. This site has a 
tropical climate with two seasons, the rainy and the dry seasons, which 
start from May-October and December-March, respectively.
This is a cross-sectional study with a cohort of children between 
6 months and 17 years. A total of 93 children were recruited from 
outpatient departments of selected healthcare facilities within the 
period of the study. Blood samples collected from the children were 
used for determination of malaria parasite status and Enzyme-linked 
Immunosorbent Assay (ELISA).
Parasitological measurements
For each blood sample collected, thick and thin blood smear was 
prepared, and then stained using Giemsa-stain technique to identify 
parasite density (PD) and Plasmodium species, respectively. Parasite 
population was obtained by counting the number of asexual parasites 
per 200 white blood cell (WBCs) counts and calculating parasites/μl 
assuming a WBC count of 8000/μl. A smear was considered negative 
if no parasites were seen after review of 100 high-powered fields. 
Parasitemia was categorized as low (<1000 parasite/μl), moderate 
(1001–10,000 parasite/μl), high (>10,001/μl), and hyperparasitemia 
(≥100,000) [10,11].
Measurement of IgG using ELISA 
The anti-malaria ELISA kit ab178649 from Abcam® was used following 
the manufacturer’s instructions. All reagents, samples and controls 
were equilibrated to room temperature (18–25°C) before use. Before 
assaying, all samples were diluted 1:100 with IgG sample diluent. 
Sample (10 µL) was added to 990 µL IgG sample diluent to obtain a 
1:100 dilution. It was mixed gently and thoroughly. Exactly 100 µL of 
sample was added into the 96-wells. The plates were sealed with foil 
paper and incubated for 1 h at room temperature. After the removal of 
the seal, the contents of the well were aspirated, each well was washed 
3 times with 300 µL of 1×washing solution. After the last wash, the 
remaining 1×washing solution was removed by decanting, the plate was 
inverted and then blotted against clean paper towels to remove excess 
liquid. A 100 µL of malaria anti-IgG conjugate was added into the wells 
and incubated for 30 min at room temperature. Subsequently, 100 µL 
of Tetramethylbenzidine (TMB) substrate solution was added into the 
wells and incubated at exactly 15 min at room temperature in the dark. 
Stop solution (100 µL) was added into the wells in the same order and 
at the same rate as for the TMB substrate solution. It was noted that any 
blue color developed during the incubation stage turned yellow. The 
absorbance of the specimen was measured at 450 nm within 30 min of 
the addition of stop solution.
Calculation and interpretation of results for ELISA
For the result calculation, the mean background subtracted absorbance 
for each sample was calculated and was compared to the mean cutoff 
control value. The cutoff control value is the mean absorbance value of 





Patients mean  absorbance value
Results in Standard Units 100
Cut off
Standard Units
Samples were considered to give a positive signal if the absorbance 
value is >10% over the cutoff value. Samples with an absorbance value 
of <10% below the cutoff value were considered as negative.
Data processing and analysis
The data were analyzed using SPSS version 23.0 statistical software 
package. The age of participants was categorized into three groups 
– 6 months–5 years, 6–11 years, 12–17 years and a control group of 
>18 years. Chi square analysis was used to determine the correlation 
between antibody responses to malaria antigens. Mann–Whitney and 
Kruskal–Wallis tests were used to test for the differences in proportions 
and determine relationships between categorical variables. Correlation 
coefficient between IgG concentrations and age was determined. A two-
tailed p<0.05 was considered statistically significant. 
RESULTS
Demographic and clinical features of the study participants
A total of 93 participants were included in the study with 45 (48.38%) 
males and 48 (51.61%) females. From this, 36 (38.70%) were below 
5 years, 29 (31.20%) were between the age of 6 and 11 years, 23 
(24.80%) aged 12 and 17 years, and a control group of >18 years 
with 5 (5.30%) (Table 1). Meanwhile, 84 (90.32%) were infected with 
P. falciparum and observed positive by microscopy. 
IgG antibody response to P. falciparum infection
From the study, generally, there was a high seroprevalence of IgG 
antibody against P. falciparum antigens tested with 69 (74.20%). The 
frequency of a non-reactive response to an antigen was 17 (18.27%). 
There was no production of antibody, which was an indication of 
the absence of P. falciparum. Furthermore, an indeterminate group 
– the grey zone (may occur either due to the patient recently infected 
with the P. falciparum pathogen or possess the low strength of the 
pathogen), recorded 7 (7.52%). Meanwhile, from the total of 93 
samples exposed to ELISA, 84 (90.32%) of the samples were infected 
with P. falciparum whilst, 9 (9.67%) tested negative with microscopy. 
Interestingly, of the nine cases (9.67%) tested negative with 
microscopy, more than half of the samples (5) produced IgG antibody 
against the antigens (Table 2). In contrast, cases with P. falciparum 
infection recorded higher specific IgG antibody responses 64 
(68.81%) as compared to negative P. falciparum cases, suggesting a 
strong relationship between production of specific antibodies and P. 
falciparum transmission, rather than protective immunity. Analysis 
using the Mann–Whitney U-test revealed a non-significant difference 
(p>0.05) in IgG antibody response to P. falciparum infection between 
negative P. falciparum cases and P. falciparum infected cases. In 
addition, a non-significant negative correlation between the negative 
and positive P. falciparum parasite and the production of antibody IgG 
was recorded at p>0.05.
IgG antibody response to P. falciparum PD
The highest seroprevalence of IgG antibody response to P. falciparum 
antigen was detected in plasma samples with high Parkinson’s disease 
9 (90.00%). This was then followed by those with low PD 13 (81.25%), 
and the least observed seroprevalence of P. falciparum IgG antibody was 
observed in samples with moderate PD 42 (72.41%) (Table 3).
The differences in the seroprevalence of P. falciparum IgG antibody 
were not significant (p>0.05) between all the PD (low, moderate, and 
high parasitemia) and non-significant association exists between 
them (p>0.05). For variation between the IgG antibody and the PD, 
significant difference (p>0.05) was not observed between P. falciparum 
infected erythrocyte and PD using Analysis of Variance. Furthermore, 
Kruskal–Wallis H test was used to determine variations in IgG response 
Table 1: Demographic features of the study participants 
Age/Sex Male (%) Female (%) Total (%)
6 month–5 year 21 (47.00) 15 (31.30) 36 (38.70)
6 year–11 year 11 (24.00) 18 (37.50) 29 (31.20)
12 year–17 year 10 (22.00) 13 (27.10) 23 (24.80)
>18 year (control) 3 (7.00) 2 (4.10) 5 (5.30)
Total 45 (100) 48 (100) 93 (100)
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between the different categories of PD, and a statistically non-significant 
difference was observed in all the categories of PD (p>0.05).
Fig. 1 shows a boxplot of the distribution of IgG absorbance values at 
450 nm in P. falciparum for PD. The horizontal bars in the middle of each 
box indicate the mean percentage of OD. The top and bottom of each 
box represent the upper and lower quartiles, respectively. 
IgG antibody responses to P. falciparum in relation to sex and age
From this study, it was recorded that both the male and female category 
had prevalence of reactive samples, that is, samples that produced IgG 
antibody against P. falciparum antigen, and were quite higher in male 
category with 35/45 (77.77%) and 34/48 (70.83%), respectively. The 
highest seroprevalence was observed in older children. The frequency 
of a non-reactive response to an antigen was 17/93 (18.27%) with 
8/45 (17.77%) in male and 9/48 (18.75%) from the female category. 
Furthermore, an indeterminate group – the grey zone also recorded a 
total 7/93 cases (7.52%) with male category having 2/45 (4.44%) and 
female category with 5/48 (10.41%). This effect could be as a result 
that either the patients were recently infected with the P. falciparum 
pathogen or they possess the low strength of the pathogen (Table 4).
Analysis using the Mann–Whitney U-test, however, revealed IgG 
antibody response to P. falciparum infection in the male was significantly 
different from that of the female category (p<0.05). In addition, the 
differences in the seroprevalence of P. falciparum IgG antibody response 
to the antigen were not significant (p>0.05) with age and no significant 
association exists between them. Furthermore, Kruskal–Wallis H test 
was used to test for variation between the age groups and it showed 
a non-significant difference in IgG antibody response between the age 
groups (p>0.05).
Fig. 2 shows a boxplot of the distribution of IgG absorbance values at 
450 nm in P. falciparum for male and female. The mean absorbance 
recorded was 45 SU and 25 SU; the lower quartiles of 5 SU and 5 SU; 
and an upper quartiles of 65 SU and 63 SU for both male and female 
groups, respectively. Meanwhile, Fig. 3 also showed a box plot of the 
distribution of IgG absorbance values at 450 nm in P. falciparum for 
different cohorts. The horizontal bars for mean absorbance were 
recorded as 25 SU, 32 SU, 50 SU, and 48 SU; the lower quartiles of 2 SU, 
4 SU, 5 SU, and 24 SU; and an upper quartiles of 70 SU, 67 SU, 69 SU, and 
68 SU for age groups 6 months–5 years, 6–11 years, 12–17 years, and 
>18 years, respectively.
DISCUSSION
In this study, the relationship between IgG antibody responses 
to P. falciparum parasite populations in children with malaria infections 
was assessed in Minna, Niger State, North-Central Nigeria. There was 
a high seroprevalence of antibodies in general, against P. falciparum 
antigens tested with about 74%. The findings from this study were 
supported by the previous work which reported a high seroprevalence 
and protective role of antibodies in the endemic Dielmo area [12] (Diop 
et al., 2014), and also in another study by Nazareth et al. (2017) [13], 
where a synthetic malaria antigen was used, with about three-quarters 
(78.80%) of the participants positive for total IgG antibodies to the 
antigen (AS202.11 peptide).
Samples detected by microscopy with P. falciparum had higher specific 
antibody IgG responses compared to negative P. falciparum samples, 
suggesting a strong relationship between production of specific 
antibodies and P. falciparum transmission, rather than protective 
immunity, in other words, the studied specific antibody IgG responses 
appeared thus to be associated with malaria infection rather than anti-
malarial protective immunity and this could also be a proof that the 
antibody served as a potential markers of both exposure to P. falciparum 
and protection against disease. This was discussed by Sarr et al. 
Table 4: Immunoglobulin G antibody to P. falciparum in relation to sex and age
Sex Overall Male Female


















6 month–5 year 9 (25.00) 3 (8.33) 24 (66.66) 5 (23.80) 2 (9.50) 14 (66.66) 4 (26.66) 1 (6.66) 10 (66.66)
6 year–11 year 4 (13.80) 4 (13.80) 21 (72.41) 1 (9.09) 0 (0.00) 10 (90.90) 3 (16.66) 4 (22.22) 11 (61.11)
12 year–17 year 4 (17.40) 0 (0.00) 19 (82.60) 2 (20.00) 0 (0.00) 8 (80.00) 2 (15.38) 0 (0.00) 11 (84.61)
>18 year (control) 0 (0.00) 0 (0.00) 5 (100.00) 0 (0.00) 0 (0.00) 3 (100.00) 0 (0.00) 0 (0.00) 2 (100.00)
Total 17 (18.27) 7 (7.52) 69 (74.19) 8 (17.77) 2 (4.44) 35 (77.77) 9 (18.75) 5 (10.41) 34 (70.83)
P. falciparum: Plasmodium falciparum 











Negative 9 3 (33.33) 1 (11.11) 5 (55.55)
Low PD (<1000/μl) 16 2 (12.50) 1 (6.25) 13 (81.25)
Moderate PD 
(1001–10,000/μl)
58 11 (18.96) 5 (8.62) 42 (72.41)
High PD  
(>10,001/μl)
10 1 (10.00) 0 (0.00) 9 (90.00)
Total 93 17 (18.27) 7 (7.52) 69 (74.19)
P. falciparum: Plasmodium falciparum, PD: Parasite density
Fig. 1: Boxplot of the distribution of immunoglobulin G 
absorbance values at 450 nm in Plasmodium falciparum for 
parasite density









Non-reactive (<9) 3 (3.22) 14 (15.05) 17 (18.27)
Grey zone (9–11) 1 (1.07) 6 (6.45) 7 (7.52)
Positive (>11) 5 (5.37) 64 (68.81) 69 (74.20)
Total 9 (9.67) 84 (90.32) 93 (100)
P. falciparum: Plasmodium falciparum 
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(2007) [14], in their study which states that children with P. falciparum 
infection had higher specific antibody responses compared to negative 
infection children. 
Meanwhile, of the 9% microscopically negative P. falciparum samples, 
more than half produced antibodies to P. falciparum antigens. This 
could also be a proof of a sub-microscopic parasite and is evident for 
boosting immune responses by these sub-microscopic parasites. This 
observation was in line with other studies from low transmission 
settings [15,16], but was not in agreement with a previous study in an 
intense malaria transmission setting in Uganda [17], and also in Kenya, 
Lake Victoria [18].
However, associations between antibody responses to P. falciparum 
antigen and the risk of P. falciparum infection have shown to be 
statistically non-significant. This observation was inconsistent in 
multiple studies [19]. Potential reasons for these inconsistencies may 
include differences in the intensity and stability of transmission, allelic 
variation of specific antigens, and IgG subclass switching [3]. 
The influence of microscopically detectable PD to prevalence of antibody 
responses in this study shows that samples with high PD showed the 
highest seroprevalence, with 90% that produced IgG antibody against 
the P. falciparum antigens. This was then followed by samples with low 
PD with 81% and the least seroprevalence in this category was found 
in samples with moderate PD 72%. Contrary to the previous findings in 
Lake Victoria, Kenya by Idris et al. (2017) [18], an increase IgG antibody 
levels was observed with PD. Furthermore, in line with the previous 
studies by Idris et al. (2017) [18], the differences in the seroprevalence 
of P. falciparum antibody from this study were not significant (p>0.05) 
between PD (low, moderate, and high parasitemia) and no significant 
association exists between them; and this was also observed in a similar 
work conducted by Ismail et al. (2017) [20], which states that there was 
no correlation between initial parasitemia and the presence of either 
IgG or IgM with any of the tested antigens, as measured by ELISA. 
The result obtained from this study was quite similar with a previous 
work conducted between two villages by Sarr et al. (2007) [14], that 
states that a correlation was observed between the intensity of malaria 
infection (number of P. falciparum parasite/µl of blood) and Antibody 
responses in Mboula (r=0.332, p=0.02), whereas in Gankette Balla the 
correlation (r=0.047) was not significant.
Seroprevalence to P. falciparum IgG antibody increased with age, though 
no statistical significant differences between them (p>0.05). There 
were conflicting results as to whether the production of antibody as a 
result of P. falciparum infection increases or decreases with age, from 
the previous studies. Nazareth et al. (2017) [13] observed a statistical 
differences in the seropositivity between the youngest (≤12 years) 
and the other age categories; but did not differ significantly between 
the middle age (13–40 years) and the older (>40 years) categories. 
Niang et al. (2017) [21] observed a low (47.19%) and high (89.45%) 
seroprevalences to Pfsch07/03 (P. falciparum schizonts) antibodies, 
respectively, in children and older adults. This was further elucidated 
from this study where all control samples (which were adults) 
produced antibodies against P. falciparum antigens and thus could 
also be as a result of more previous exposures to malaria infection 
in the adults. In contrast, it was also reported from a previous study 
that specific IgG responses increased progressively in children aged 
from 1 to 5 years and then stay high until eight. In another study by 
Idris et al. (2017) [18], it states that P. falciparum antibody prevalence 
increased with age. In the present study, the fact that seroprevalence to 
P. falciparum IgG antibody was higher in older children and even adults, 
P. falciparum appears to be a factor of variation of the age-dependent 
development of anti-malarial IgG responses.
Seroprevalence to P. falciparum antibody IgG observed in male was 
quite higher as compared to the female category (77.77% and 70.83%, 
respectively) with statistical significant difference between them, 
indicating non similar exposure (i.e., males have more exposure to the 
parasite) between the two groups.
CONCLUSION
Findings from this study revealed differences in seroprevalence of age 
and sex, and it was categorically discovered that the male had higher 
risk of exposure to the parasite. The seroprevalence of P. falciparum 
antigen is non-dependent on the age of the child. However, cases with 
microscopically detectable high PD (severe malaria) observed the 
highest seroprevalence, and this suggests that immune responses are 
more stable in this category. Similarly, an evidence (of more than 50%) 
was found for a boosting of immune responses by sub-microscopic 
parasite from this study and consequently, sub-microscopic infections 
will provide an antigenic stimulus to maintain immune responses. 
This study has several limitations: The study is a cross-sectional, and 
it provides limited information about the participants. In addition, the 
convenience sampling method used in this study has inherent selection 
bias. The survey was conducted in healthcare facilities, meaning that 
children out of the healthcare facilities and asymptomatic cases were 
not represented, though this approach is still valid to obtaining an 
estimate of seroprevalence of the parasite. The outpatient department 
of the healthcare facilities was visited by mostly children under the 
age of 5, which means that older children were under sampled. This 
study warrants further investigation in a wider population inclusive of 
asymptomatic individuals to have an inclusive picture of the dynamics 
of responses to Ig. 
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Fig. 2: Boxplot of the distribution of immunoglobulin G 
absorbance values at 450 nm in Plasmodium falciparum infection 
for male and female
Fig. 3: Boxplot of the distribution of immunoglobulin G 
absorbance values at 450 nm in Plasmodium falciparum infection 
for different age groups
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